BELINDA BECKER: Open Payments
NPI 1962000539 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 9 payments from 5 companies in 2025. Trend: 2023 $145 · 2024 $0 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $160 |
| Alexion Pharmaceuticals, Inc. | 2 | $142 |
| Lilly USA, LLC | 2 | $41 |
| Eisai Inc. | 2 | $36 |
| Invivyd Inc | 1 | $16 |
Products named: AMVUTTRA, ULTOMIRIS, OMVOH, Leqembi, GIVLAARI, PEMGARDA.
Industry payments across MI — which companies pay providers there.
